Literature DB >> 21626106

Utility of laboratory tests in B-CLL patients in different clinical stages.

Małgorzata Rusak1, Joanna Osada1, Joanna Pawlus2, Joanna Chociej-Stypułkowska1, Milena Dąbrowska1, Janusz Kłoczko3.   

Abstract

The study objective was to analyse the utility of laboratory tests performed in 30 patients with B-cell chronic lymphocytic leukaemia (B-CLL) at different clinical stages. Laboratory tests included automated and microscopic assessment of peripheral blood and bone marrow counts as well as evaluation of leukaemic cells. Apart from the diagnostic and prognostic value of laboratory abnormalities such as clonal lymphocytosis with CD5+CD19+CD23+ phenotype, reduced erythrocyte parameters, thrombocytopenia or bone marrow infiltration by the neoplastic clone as well as low percentage of Gumprecht's shadows, low apoptotic activity of peripheral blood lymphocytes, and increased percentage of CD38- and ZAP-70 ± cells markedly correlate with the stage of disease progression. These results seem to confirm the diagnostic and prognostic significance of these parameters determined in routine laboratory tests in B-CLL patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626106     DOI: 10.1007/s12185-011-0862-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach.

Authors:  Wendy G Nieto; Julia Almeida; Alfonso Romero; Cristina Teodosio; Antonio López; Ana F Henriques; Maria Luz Sánchez; María Jara-Acevedo; Ana Rasillo; Marcos González; Paulino Fernández-Navarro; Tomás Vega; Alberto Orfao
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

2.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

3.  CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.

Authors:  Krzysztof Jamroziak; Zofia Szemraj; Olga Grzybowska-Izydorczyk; Janusz Szemraj; Magdalena Bieniasz; Barbara Cebula; Krzysztof Giannopoulos; Ewa Balcerczak; Dorota Jesionek-Kupnicka; Malgorzata Kowal; Aleksandra Kostyra; Malgorzata Calbecka; Ewa Wawrzyniak; Marek Mirowski; Radzislaw Kordek; Tadeusz Robak
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

4.  Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Krzysztof Giannopoulos; Michael Schmitt; Malgorzata Kowal; Paulina Wlasiuk; Agnieszka Bojarska-Junak; Jinfei Chen; Jacek Rolinski; Anna Dmoszynska
Journal:  Oncol Rep       Date:  2008-09       Impact factor: 3.906

Review 5.  Chronic lymphocytic leukaemia.

Authors:  Jerina Boelens; Sofie Lust; Barbara Vanhoecke; Fritz Offner
Journal:  Anticancer Res       Date:  2009-02       Impact factor: 2.480

6.  CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.

Authors:  S Ibrahim; M Keating; K A Do; S O'Brien; Y O Huh; I Jilani; S Lerner; H M Kantarjian; M Albitar
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

7.  Chronic lymphocytic leukemia: "Cinderella" is becoming a star.

Authors:  Federico Caligaris-Cappio
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

Review 8.  Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.

Authors:  Martha S Linet; Mary K Schubauer-Berigan; Dennis D Weisenburger; David B Richardson; Ola Landgren; Aaron Blair; Sharon Silver; R William Field; Glyn Caldwell; Maureen Hatch; Graça M Dores
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

Review 9.  In vivo monitoring of apoptosis.

Authors:  Manfred Brauer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-04       Impact factor: 5.067

10.  Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.

Authors:  Grzegorz S Nowakowski; James D Hoyer; Tait D Shanafelt; Clive S Zent; Timothy G Call; Nancy D Bone; Betsy Laplant; Gordon W Dewald; Renee C Tschumper; Diane F Jelinek; Thomas E Witzig; Neil E Kay
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.